Alzamend Neuro Ownership | Who Owns Alzamend Neuro?


OverviewFinancialsChart

Alzamend Neuro Ownership Summary


Alzamend Neuro is owned by 6.35% institutional investors, and 93.65% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.52% of its assets in Alzamend Neuro shares.

ALZN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAlzamend Neuro6.35%-93.65%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2023244.35%6,248,4241.95%616.34%11120.00%2-60.00%
Jun 30, 202323-23.33%6,128,982-1.26%615.64%5-16.67%5-37.50%
Mar 31, 202330-14.29%6,207,291-10.82%612.60%6-71.43%814.29%
Dec 31, 202235105.88%6,960,481-12.10%710.73%21162.50%775.00%
Sep 30, 202217-29.17%7,918,843157.44%881.58%8-20.00%4-33.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Extended Market Index30.01K0.52%537.00
Vanguard Institutional Extnd Mkt Idx Tr7.85K0.12%-
Fidelity Series Total Market Index6.00K0.10%1.56K
Fidelity Nasdaq Composite Index999.000.02%-
Spartan Extended Market Index Pool F710.000.01%188.00
Fidelity Total Market Index705.000.01%-
Spartan Extended Market Index Pool E710.000.01%188.00
NT Ext Equity Mkt Idx Fd - NL374.000.01%-
NT Ext Equity Mkt Idx Fd - DC - NL - T2291.000.01%-5.00
Northern Trust Extended Eq Market Idx286.000.00%-

Insider Transactions Trends


DateBuySell
2025 Q2-2
2025 Q17-
2024 Q32-
2024 Q22-
2024 Q16-

ALZN Ownership FAQ


Who Owns Alzamend Neuro?

Alzamend Neuro shareholders are primarily institutional investors at 6.35%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Alzamend Neuro's industry, Biotech Stocks , is 63.96%, which Alzamend Neuro falls below.

Does Blackrock own Alzamend Neuro?

BlackRock is not among the top 10 institutional shareholders of Alzamend Neuro.

Who is the top mutual fund holder of Alzamend Neuro shares?

Fidelity Extended Market Index is the top mutual fund holder of Alzamend Neuro shares, with 0.52% of its total shares outstanding invested in 30.01K Alzamend Neuro shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools